PATENT CLAIM ANALYSIS

Application Number: 15968355
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "562000"]

Abstract:
The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E 2 .

Claim (Index 21):
The method of  claim 1 , wherein the subject is human.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15111144', '15147484', '15725950', '14414669', '11399033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7531737264555527
- 35 USC 102 Novelty (BERT): 0.5081889577293024
- Combined Prediction Score: 0.7286752495829276
- Mean Citation Score: 155.48370400000005
- Max Citation Score: 156.36563
- Similarity Product: 83.06179416335286

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test